Regentis Biomaterials (RGNT) Income Statement (2023 - 2025)
Annual Income Statement report data from Dec 31, 2023 to Dec 31, 2025 for Regentis Biomaterials (RGNT).
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Reported currency: USD
| 2025 | 2025 | 2024 | 2024 | 2023 | 2023 | |
|---|---|---|---|---|---|---|
Operating Expenses | ||||||
Selling General And Administrative | 6.64M (0.00%) | 6.64M (+835.21%) | 710K (0.00%) | 710K (-37.17%) | 1.13M (0.00%) | 1.13M |
Operating Expenses | 6.64M (0.00%) | 6.64M (+835.21%) | 710K (0.00%) | 710K (-37.17%) | 1.13M (0.00%) | 1.13M |
Operating Income | ||||||
Operating Income | -6.97M (0.00%) | -6.97M | 930K (0.00%) | 930K | -1.93M (0.00%) | -1.93M |
Ebit | -6.97M (0.00%) | -6.97M | 930K (0.00%) | 930K | -1.93M (0.00%) | -1.93M |
EBITDA | -13.57M (0.00%) | -13.57M | 4.81M (0.00%) | 4.81M | -4.13M (0.00%) | -4.13M |
Other Income / Expenses | ||||||
Interest Expense | 80K (0.00%) | 80K (+700.00%) | 10K (0.00%) | 10K | - | - |
Other Non Operating Income | -1.90M (0.00%) | -1.90M (+2275.00%) | -80.00K (0.00%) | -80.00K (-66.67%) | -240.00K (0.00%) | -240.00K |
Net Income | ||||||
Income Before Tax | 14M (0.00%) | 14M | -4.80M (0.00%) | -4.80M | 4.13M (0.00%) | 4.13M |
Net Income From Continuing Operations | -13.65M (0.00%) | -13.65M | 4.80M (0.00%) | 4.80M | -4.13M (0.00%) | -4.13M |
Net Income | -13.65M (0.00%) | -13.65M | 4.80M (0.00%) | 4.80M | -4.13M (0.00%) | -4.13M |